Seed Innovations Ltd - Investee Company Update: Little Green Pharma
Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments
SEED Innovations Limited
("SEED" or the "Company")
Investee Company Update: Little Green Pharma Ltd
SEED Innovations Ltd, the AIM-quoted investing company, notes an announcement released on the ASX by its legacy portfolio company, Little Green Pharma Ltd ("LGP"), regarding a proposed merger with Cannatrek.
Key highlights of the announcement are set out below. The full announcement is available at the following link:
SEED holds 7,324,796 ordinary shares in LGP, representing approximately 2.4% of LGP's issued share capital.
Little Green Pharma Ltd
Transformational Merger Of Little Green Pharma And Cannatrek
Highlights
· Little Green Pharma Ltd (ASX:LGP) ("LGP" or the "Company") and Cannatrek Ltd (Cannatrek) have today entered into a Scheme Implementation Deed (SID) under which LGP has agreed to acquire 100% of Cannatrek's issued capital by way of a scheme of arrangement (Scheme)
· Cannatrek is a leading Australian manufacturer and distributor of medicinal cannabis products, with vertically integrated operations spanning GMP-certified manufacturing, medical clinics and distribution operations
· The Scheme consideration will comprise LGP ordinary shares and new LGP contingent value shares, with existing LGP shareholders holding ~39.5% and Cannatrek shareholders holding ~60.5% of the fully diluted issued capital in LGP at Completion, and with Cannatrek Shareholders additionally holding contingent value shares (CV Shares) that based on the outcome of future events may convert into ordinary LGP shares and increase Cannatrek shareholder holdings by up to an additional eight percent
· The Cannatrek Board representing ~22% of the Cannatrek shares on issue unanimously recommends the Scheme, and the Cannatrek Directors intend to vote all Cannatrek shares in which they have a relevant interest in favour of the Scheme, in the absence of a superior proposal and subject to the Independent Expert concluding (and continuing to conclude) that the Scheme is in the best interests of Cannatrek shareholders
· The LGP Board representing 13.1% of the LGP shares on issue unanimously recommend the proposed merger, and intend to vote all LGP shares in which they have a relevant interest in favour of the issue of merger consideration shares in the absence of a superior proposal
· The proposed merger will create a leading fully vertically integrated medicinal cannabis group (Combined Group) with operations spanning cultivation, GMP-certified manufacturing and packaging, distribution and clinic and digital health channels in
· The transaction is consistent with LGP's prior market disclosures regarding its strategy of industry consolidation and market rationalisation and reflects the increasing importance of size in the Australian and European medicinal cannabis markets, where operational scale, brand recognition and distribution capability are key drivers for market share growth and long-term competitiveness
· If the Scheme is implemented, based on a simple amalgamation of the 2025 financial year results the pro forma Combined Group would have had
· Synergy opportunities are expected to come from such areas as leveraging Cannatrek's latent Australian GMP-certified manufacturing for the Australian market and LGP Denmark's latent GMP-certified manufacturing capacity for European markets; combining clinic operations; and optimising cost and expense management
· The strength of Cannatrek's balance sheet will accelerate the scaling and growth of LGP's European operations. This is expected to be a principal growth engine for the Combined Group in the short term, particularly as
· The Combined Group will also provide a platform for further international expansion, via both acquisition and investment and organic growth initiatives
- Ends -
For further information on the Company please visit: www.seedinnovations.co or contact:
|
|
SEED Innovations Ltd |
|
|
|
Beaumont Cornish Limited, Nomad |
T: (0)20 7628 3396
|
|
|
Shard Capital Partners LLP Broker |
T: (0)20 7186 9927 |
|
|
St Brides Partners Ltd, Financial PR |
NOTES
Seed Innovations Ltd
SEED Innovations Ltd (SEED.L) is an AIM-quoted investing company focused on providing access to high-growth robotics and AI ventures typically beyond the reach of everyday investors. The Company also oversees a legacy portfolio in wellness and life sciences, with a medium-term strategy to unlock its full value. Back by an experienced team and strong cash reserves, the Company remains agile and well-positioned to capitalise on new investing opportunities as they arise.
Nominated Adviser
Beaumont Cornish Limited ("
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE